These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 24138903

  • 1. Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.
    Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Huang YC, Chen HJ, Syu JJ, Chen CY, Jian YT, Jian YJ, Lin YW.
    Lung Cancer; 2013 Dec; 82(3):397-406. PubMed ID: 24138903
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL, Chiu HC, Jian YJ, Jian YT, Chen CY, Syu JJ, Wo TY, Huang YJ, Tseng SC, Lin YW.
    Exp Cell Res; 2014 Apr 01; 322(2):345-54. PubMed ID: 24530475
    [Abstract] [Full Text] [Related]

  • 3. Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.
    Tseng SC, Huang YC, Chen HJ, Chiu HC, Huang YJ, Wo TY, Weng SH, Lin YW.
    Biochem Pharmacol; 2013 Feb 15; 85(4):583-94. PubMed ID: 23228696
    [Abstract] [Full Text] [Related]

  • 4. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Tung CL, Jian YJ, Chen JC, Wang TJ, Chen WC, Zheng HY, Chang PY, Liao KS, Lin YW.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun 15; 389(6):657-66. PubMed ID: 27026405
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
    Tsai MS, Weng SH, Chen HJ, Chiu YF, Huang YC, Tseng SC, Kuo YH, Lin YW.
    Mol Cancer Ther; 2012 Mar 15; 11(3):561-71. PubMed ID: 22053010
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells.
    Ko JC, Chen JC, Wei CL, Liu LL, Chien CC, Huang IH, Hsieh JM, Chiang CS, Tseng PY, Cheng HH, Tsao YC, Lin YW.
    Pharmacology; 2021 Mar 15; 106(11-12):623-636. PubMed ID: 34753130
    [Abstract] [Full Text] [Related]

  • 7. Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells.
    Chen RS, Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Chen HJ, Huang YC, Jian YJ, Lee WT, Lin YW.
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec 15; 386(12):1047-59. PubMed ID: 23912706
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
    Morgillo F, Sasso FC, Della Corte CM, Vitagliano D, D'Aiuto E, Troiani T, Martinelli E, De Vita F, Orditura M, De Palma R, Ciardiello F.
    Clin Cancer Res; 2013 Jul 01; 19(13):3508-19. PubMed ID: 23695170
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells.
    Ko JC, Chiu HC, Syu JJ, Chen CY, Jian YT, Huang YJ, Wo TY, Jian YJ, Chang PY, Wang TJ, Lin YW.
    Biochem Biophys Res Commun; 2015 Jan 02; 456(1):506-12. PubMed ID: 25490383
    [Abstract] [Full Text] [Related]

  • 10. Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.
    Galan-Moya EM, de la Cruz-Morcillo MA, Llanos Valero M, Callejas-Valera JL, Melgar-Rojas P, Hernadez Losa J, Salcedo M, Fernández-Aramburo A, Ramon y Cajal S, Sánchez-Prieto R.
    PLoS One; 2011 Jan 02; 6(12):e28406. PubMed ID: 22164285
    [Abstract] [Full Text] [Related]

  • 11. Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells.
    Makeeva N, Myers JW, Welsh N.
    Biochem J; 2006 Jan 01; 393(Pt 1):129-39. PubMed ID: 16097952
    [Abstract] [Full Text] [Related]

  • 12. [Small molecule inhibitor SB203580 enhances the antitumor effect of gefitinib in PC-9 and A549 lung cancer cell lines].
    Zhao YM, Su B, Yang XJ, Shi JY, Tang L, Zhang J, Li JY, Chen J.
    Zhonghua Zhong Liu Za Zhi; 2013 Feb 01; 35(2):103-8. PubMed ID: 23714663
    [Abstract] [Full Text] [Related]

  • 13. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Otto KB, Acharya SS, Robinson VL.
    Urol Oncol; 2012 Feb 01; 30(4):415-20. PubMed ID: 22154358
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA, Vellon L, Colomer R, Lupu R.
    Int J Cancer; 2005 May 20; 115(1):19-35. PubMed ID: 15657900
    [Abstract] [Full Text] [Related]

  • 15. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
    Ko JC, Ciou SC, Cheng CM, Wang LH, Hong JH, Jheng MY, Ling ST, Lin YW.
    Carcinogenesis; 2008 Jul 20; 29(7):1448-58. PubMed ID: 18544565
    [Abstract] [Full Text] [Related]

  • 16. MKK3/6-p38 MAPK negatively regulates murine MMP-13 gene expression induced by IL-1beta and TNF-alpha in immortalized periodontal ligament fibroblasts.
    Rossa C, Liu M, Patil C, Kirkwood KL.
    Matrix Biol; 2005 Oct 20; 24(7):478-88. PubMed ID: 16046111
    [Abstract] [Full Text] [Related]

  • 17. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells.
    Ko JC, Ciou SC, Jhan JY, Cheng CM, Su YJ, Chuang SM, Lin ST, Chang CC, Lin YW.
    Mol Cancer Res; 2009 Aug 20; 7(8):1378-89. PubMed ID: 19671683
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells.
    Tung CL, Jian YJ, Syu JJ, Wang TJ, Chang PY, Chen CY, Jian YT, Lin YW.
    Exp Cell Res; 2015 May 15; 334(1):126-35. PubMed ID: 25662161
    [Abstract] [Full Text] [Related]

  • 19. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
    Rossa C, Ehmann K, Liu M, Patil C, Kirkwood KL.
    J Interferon Cytokine Res; 2006 Oct 15; 26(10):719-29. PubMed ID: 17032166
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS.
    Oncol Rep; 2012 Nov 15; 28(5):1799-807. PubMed ID: 22923287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.